Theravance Biopharma (TBPH) Tax Rate (2014 - 2026)

Theravance Biopharma (TBPH) has 13 years of Tax Rate data on file, last reported at 23.18% in Q1 2026.

• On a quarterly basis, Tax Rate rose 1923.0% year-over-year to 23.18% in Q1 2026; TTM through Mar 2026 was 29.24%, a 4988.0% increase from a year earlier, with the FY2025 full-year figure at 32.17%, up 5863.0% from the prior year.
• Tax Rate for Q1 2026 stood at 23.18%, down from 45.13% in the prior quarter.
• Over the last five years, Tax Rate for TBPH reached as high as 225.13% in Q3 2025 and fell as low as 73.7% in Q4 2024.
• Historically, Tax Rate has averaged 10.08% across 5 years, with a median of 0.02% in 2022.
• Across the five-year window, Tax Rate plunged 6798 bps in 2024 and jumped 25145 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 0.02% in 2022, then tumbled by 27295 bps to 5.72% in 2023, then plunged by 1188 bps to 73.7% in 2024, then jumped by 161 bps to 45.13% in 2025, then plunged by 49 bps to 23.18% in 2026.
• Per Business Quant data, the three most recent Tax Rate figures were 23.18% in Q1 2026, 45.13% in Q4 2025, and 225.13% in Q3 2025.